title: Leukaemia inhibitory factor (LIF) upregulates excitatory non-adrenergic non-cholinergic and maintains cholinergic neural function in tracheal explants.
abstract: The effect of leukaemia inhibitory factor (LIF) in modulating cholinergic and sensory nerve function was examined using guinea-pig tracheal explants. Specific LIF receptors (LIFR) were immunolocalized to both cholinergic and sensory nerves. Release of SP in culture was not influenced by LIF. Similarly, maximum contraction to carbachol (C(max)) was not influenced by LIF. After 3 h, maximum (E(max)) eNANC-induced contraction in controls was 32+/-2. 5% of C(max). In LIF-treated preparations, E(max) was enhanced to 50+/-4.5% C(max) (P<0.05). Cholinergic nerve-induced contractions after 3 h incubation with LIF were similar to control. After 24 h, control E(max) was 25+/-4.5% C(max) (58% smaller than E(max) at 3 h). In contrast, in LIF-treated preparations, E(max) was 37+/-2.5% C(max), (24% smaller than at 3 h, P<0.05). This did not appear to be due to the effect of LIF on muscarinic M(2) receptor expression or function. Thus LIF appears to differentially influence the function of airway nerves and thus may provide an important link between the immune and neural systems.
authors.affiliation: Asthma & Allergy Research Institute Inc, University of Western Australia, Nedlands, 6009 Western Australia, Australia. dknight@cyllene.uwa.edu.au
authors.forename: D A
authors.initials: DA
authors.lastname: Knight
authors.forename: A C
authors.initials: AC
authors.lastname: D'Aprile
authors.forename: L J
authors.initials: LJ
authors.lastname: Spalding
authors.forename: R G
authors.initials: RG
authors.lastname: Goldie
authors.forename: P J
authors.initials: PJ
authors.lastname: Thompson
mesh_terms: D000818:Animals; D002217:Carbachol / Q000494:pharmacology; D006131:Growth Inhibitors / Q000494:pharmacology*; D006168:Guinea Pigs; D015850:Interleukin-6; D053605:Leukemia Inhibitory Factor; D008222:Lymphokines / Q000494:pharmacology*; D009119:Muscle Contraction / Q000187:drug effects; D009504:Neutrophils / Q000502:physiology; D043585:Receptor, Muscarinic M2; D018121:Receptors, Cytokine / Q000032:analysis; D011976:Receptors, Muscarinic / Q000187:drug effects / Q000235:genetics / Q000502:physiology; D053606:Receptors, OSM-LIF; D013373:Substance P / Q000378:metabolism; D014132:Trachea / Q000187:drug effects* / Q000294:innervation / Q000502:physiology
chemical_list: D006131:Growth Inhibitors; D015850:Interleukin-6; D053605:Leukemia Inhibitory Factor; D008222:Lymphokines; D043585:Receptor, Muscarinic M2; D018121:Receptors, Cytokine; D011976:Receptors, Muscarinic; D053606:Receptors, OSM-LIF; D013373:Substance P; D002217:Carbachol